TSC Ratings' Updates: Biogen Idec
Biogen Idec and, Check Point are upgraded; Allstate, Starwood and Newell Rubbermaid are downgraded.
04:18PM 01/30/09
Biotech Scorecard: My Best and Worst Calls
Biotech expert Adam Feuerstein grades his hits and misses for 2008.
06:59AM 01/02/09
Here's a look back at the hits, misses and notable moments from 2008.
12:20PM 12/29/08
Biotech-Stock Mailbag: Amgen, MiddleBrook
Examining Amgen's discount; updating MiddleBrook; valuing Seattle Genetics; and comparing SuperGen to Celgene.
07:59AM 07/04/08
MiddleBrook Sinks as Buyout Hopes Fade
The drugmaker, which had been up for sale, instead takes a $100 million equity investment. The stock sinks.
09:23AM 07/02/08
Biotech Notebook: Vertex, Medicines Co.
Uncertain regulation hangs on Vertex's telaprevir, The Medicines Co. remains mum on Cleviprex and a summer biotech-stock watch list.
10:09AM 06/10/08
Feuerstein's Biotech-Stock Mailbag
Breaking down Introgen's latest data, MiddleBrook's courtship chances, what's right at Gilead, and more.
10:36AM 05/30/08
Feuerstein's Biotech-Stock Mailbag
A health stock rebound? Plus, my take on Onyx and M&A speculation fun.
11:41AM 04/05/08
Big Money Steers Clear of Biotech
As investors shy away from risk, this week's BIO CEO confab was a bleak affair.
01:16PM 02/14/08
Feuerstein's Biotech-Stock Mailbag
Middlebrook Pharma still has some upside left.
12:00PM 01/26/08
Thursday's Winners & Losers: Security Capital Assurance
Shares drop 30.61% after Fitch Ratings stripped the company of its triple-A rating.
04:31PM 01/24/08



Connect with TheStreet